Listed by the USPTO as DARB, HAMZA A.
Tech Center 3700 • Art Units: 1645 3763 3783
This examiner grants 74% of resolved cases
DARB, HAMZA A. has resolved 554 cases in Tech Center 3700 and Art Unit 1645. The allowance rate is 74.0%, and the median time to allowance is 1233 days. The interview-lift measure is 30.8%, providing a substantial reason to consider examiner interviews.
The listed companies are Boston Scientific Corporation, Aita Bio Inc., and Becton, Dickinson and Company. The leading firms are Davidson Kappel LLC - AiTA Bio, Secant IP, PLLC, and BIOTECH BEACH LAW PC. Counsel can align technical claim analysis with a prepared interview agenda.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17851889 | SYSTEM AND METHOD FOR RESISTANCE-DEPENDENT, SELF-REGULATED MEDICAL PENETRATION | Final Rejection | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. |
| 18283685 | PERILESIONAL TREATMENT OF SKIN CONDITIONS | Final Rejection | Veradermics Incorporated |
| 18818959 | PROXIMAL EMBOLIC PROTECTION DEVICE FOR CAROTID STENTING | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18800676 | SYSTEMS AND METHODS FOR CONTROLLING NEEDLE PENETRATION | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18429685 | MICROCATHETER MANIFOLD ADAPTER AND ASSOCIATED SYSTEMS AND METHODS | Final Rejection | BOSTON SCIENTIFIC SCIMED, INC. |
| 18721433 | FLUOROSCOPIC IMAGE GUIDED ROBOTIC BLOOD VESSEL CANNULATION | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18743332 | DRUG DELIVERY DEVICE HAVING DAMPING MECHANISM | Non-Final OA | AMGEN INC. |
| 18720705 | AMMONIUM SULFATE TREATED SYRINGE FOR INCREASED PHARMACEUTICAL COMPOSITION STABILITY | Non-Final OA | Bayer HealthCare LLC |
| 17955375 | HIGH FLEXIBILITY IMPLANT CATHETER WITH LOW COMPRESSION | Non-Final OA | Edwards Lifesciences Corporation |
| 18514135 | ADD-ON WITH ACTUATOR FOR A DRUG DELIVERY DEVICE | Final Rejection | Ypsomed AG |
| 18611540 | SECURE INPUT ON A CONTROL COMPONENT FOR A DIALYSIS MACHINE | Non-Final OA | Fresenius Medical Care Deutschland GmbH |
| 18902423 | INJECTION PEN WITH DIAL BACK AND LAST DOSE CONTROL | Non-Final OA | Becton, Dickinson and Company |
| 18075220 | INTRODUCER NEEDLE HAVING A FLASHBACK NOTCH AND RELATED DEVICES | Final Rejection | Becton, Dickinson and Company |
| 18310109 | DRUG-ELUTING OCULAR IMPLANT | Non-Final OA | GLAUKOS CORPORATION |
| 18706823 | Sub-assembly for a medicament delivery device | Final Rejection | SHL Medical AG |
| 18045842 | DRIVETRAIN FOR ELONGATED MEDICAL DEVICE | Final Rejection | Corindus, Inc. |
| 18460719 | DRUG DELIVERY DEVICE | Non-Final OA | SENSILE MEDICAL AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy74.0% of resolved applications examined by Hamza A. Darb were allowed (554 resolved cases), compared with 49.4% across Art Unit 1645 over the last five years.
This examiner's interview lift is +30.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Hamza A. Darb took 1,233 days on average from filing to allowance.
Hamza A. Darb examines applications in Art Unit 1645 in Tech Center 3700 (Medical Devices & Mechanical Engineering).